Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
ImExHS Limited ( (AU:IME) ) has provided an announcement.
IMEXHS Limited reported a 9.5% increase in revenue to $28.97 million for the year ended 31 December 2025, while its net loss after tax widened slightly to $2.88 million compared with $2.63 million a year earlier. Despite the ongoing losses and the absence of dividends, the total comprehensive loss narrowed significantly to $1.51 million, and net tangible assets per share improved to 17.10 cents from 13.84 cents, suggesting a strengthening balance sheet even as auditors highlighted going-concern considerations.
The board noted that no dividends were paid or declared for the period, reflecting the company’s continued focus on reinvestment and financial consolidation. The audited accounts received an unmodified opinion with an emphasis on going concern, underlining both the progress in asset backing and the need for sustained operational improvement to reach profitability.
The most recent analyst rating on (AU:IME) stock is a Buy with a A$0.50 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
IMEXHS Limited is a healthcare technology company that provides medical imaging and radiology software solutions. The company focuses on cloud-based platforms and digital diagnostics for hospitals, clinics, and imaging centers, targeting growth in technology-enabled healthcare services.
Average Trading Volume: 17,841
Technical Sentiment Signal: Hold
Current Market Cap: A$21.89M
For detailed information about IME stock, go to TipRanks’ Stock Analysis page.